Cover Page
Cover Page - shares | 6 Months Ended | |
Jun. 30, 2021 | Aug. 02, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-36875 | |
Entity Registrant Name | EXTERRAN CORPORATION | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 47-3282259 | |
Entity Address, Address Line One | 11000 Equity Drive | |
Entity Address, City or Town | Houston | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 77041 | |
City Area Code | 281 | |
Local Phone Number | 836-7000 | |
Title of 12(b) Security | Common Stock, $0.01 par value per share | |
Trading Symbol | EXTN | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 32,291,878 | |
Entity Central Index Key | 0001635881 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q2 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 45,493 | $ 40,318 |
Restricted cash | 978 | 3,410 |
Accounts receivable, net of allowance of $10,307 and $10,803, respectively | 202,899 | 198,028 |
Inventory (Note 4) | 107,788 | 109,837 |
Contract assets (Note 2) | 32,528 | 32,642 |
Other current assets | 20,329 | 19,810 |
Current assets associated with discontinued operations (Note 3) | 21,795 | 25,325 |
Total current assets | 431,810 | 429,370 |
Property, plant and equipment, net (Note 5) | 663,137 | 733,222 |
Long-term contract assets (Note 2) | 17,537 | 33,563 |
Operating lease right-of-use assets | 23,012 | 25,428 |
Deferred income taxes | 6,079 | 8,866 |
Intangible and other assets, net | 74,893 | 71,436 |
Long-term assets associated with discontinued operations (Note 3) | 1,687 | 1,606 |
Total assets | 1,218,155 | 1,303,491 |
Current liabilities: | ||
Accounts payable, trade | 46,375 | 60,078 |
Accrued liabilities | 116,693 | 94,404 |
Contract liabilities (Note 2) | 94,669 | 100,123 |
Current operating lease liabilities | 5,781 | 6,340 |
Current liabilities associated with discontinued operations (Note 3) | 4,169 | 13,707 |
Total current liabilities | 267,687 | 274,652 |
Long-term debt (Note 6) | 573,307 | 562,325 |
Deferred income taxes | 1,465 | 1,014 |
Long-term contract liabilities (Note 2) | 69,804 | 80,499 |
Long-term operating lease liabilities | 27,945 | 29,868 |
Other long-term liabilities | 43,539 | 57,159 |
Long-term liabilities associated with discontinued operations (Note 3) | 1,267 | 2,142 |
Total liabilities | 985,014 | 1,007,659 |
Commitments and contingencies (Note 14) | ||
Stockholders’ equity: | ||
Preferred stock, $0.01 par value per share; 50,000,000 shares authorized; zero issued | 0 | 0 |
Common stock, $0.01 par value per share; 250,000,000 shares authorized; 38,028,772 and 37,804,206 shares issued, respectively | 380 | 378 |
Additional paid-in capital | 752,408 | 750,506 |
Accumulated deficit | (483,616) | (418,529) |
Treasury stock — 4,736,601 and 4,665,560 common shares, at cost, respectively | (57,741) | (57,431) |
Accumulated other comprehensive income | 21,710 | 20,908 |
Total stockholders' equity | 233,141 | 295,832 |
Total liabilities and stockholders’ equity | $ 1,218,155 | $ 1,303,491 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance (US dollars) | $ 10,307 | $ 10,803 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 250,000,000 | 250,000,000 |
Common stock, shares issued | 38,028,772 | 37,804,206 |
Treasury stock, common shares | 4,736,601 | 4,665,560 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Revenues (Note 2): | ||||
Revenues (Note 2): | $ 146,199 | $ 131,057 | $ 282,363 | $ 291,851 |
Costs and expenses: | ||||
Cost of sales (excluding depreciation and amortization expense): | 78,295 | 75,153 | 147,224 | 166,725 |
Selling, general and administrative | 33,630 | 31,530 | 66,261 | 65,090 |
Depreciation and amortization | 45,709 | 32,306 | 88,208 | 64,257 |
Impairment | 7,959 | 0 | 7,959 | 0 |
Restructuring and other charges (Note 9) | (370) | 3,105 | 254 | 3,312 |
Interest expense | 10,357 | 9,638 | 20,321 | 19,591 |
Gain on extinguishment of debt (Note 6) | 0 | (2,644) | 0 | (2,644) |
Other (income) expense, net | (3,159) | (2,641) | (98) | (2,347) |
Costs and expenses: | 172,421 | 146,447 | 330,129 | 313,984 |
Loss before income taxes | (26,222) | (15,390) | (47,766) | (22,133) |
Provision for income taxes (Note 10) | 8,836 | 3,895 | 16,292 | 13,225 |
Loss from continuing operations | (35,058) | (19,285) | (64,058) | (35,358) |
Loss from discontinued operations, net of tax (Note 3) | (156) | (12,604) | (1,029) | (14,835) |
Net loss | $ (35,214) | $ (31,889) | $ (65,087) | $ (50,193) |
Basic net loss per common share | ||||
Loss from continuing operations per common share (in dollars per share) | $ (1.06) | $ (0.59) | $ (1.94) | $ (1.08) |
Loss from discontinued operations per common share (in dollars per share) | (0.01) | (0.38) | (0.03) | (0.45) |
Net loss per common share (in dollars per share) | (1.07) | (0.97) | (1.97) | (1.53) |
Diluted net loss per common share | ||||
Loss from continuing operations per common share (in dollars per share) | (1.06) | (0.59) | (1.94) | (1.08) |
Loss from discontinued operations per common share (in dollars per share) | (0.01) | (0.38) | (0.03) | (0.45) |
Net loss per common share (in dollars per share) | $ (1.07) | $ (0.97) | $ (1.97) | $ (1.53) |
Weighted average common shares outstanding used in net loss per common share (Note 13): | ||||
Basic (in shares) | 33,056 | 32,803 | 33,003 | 32,720 |
Diluted (in shares) | 33,056 | 32,803 | 33,003 | 32,720 |
Contract operations | ||||
Revenues (Note 2): | ||||
Revenues (Note 2): | $ 87,498 | $ 77,945 | $ 168,512 | $ 172,733 |
Costs and expenses: | ||||
Cost of sales (excluding depreciation and amortization expense): | 27,764 | 23,746 | 51,108 | 55,206 |
Aftermarket services | ||||
Revenues (Note 2): | ||||
Revenues (Note 2): | 29,401 | 24,993 | 54,521 | 52,902 |
Costs and expenses: | ||||
Cost of sales (excluding depreciation and amortization expense): | 23,422 | 19,020 | 43,434 | 40,201 |
Product sales | ||||
Revenues (Note 2): | ||||
Revenues (Note 2): | 29,300 | 28,119 | 59,330 | 66,216 |
Costs and expenses: | ||||
Cost of sales (excluding depreciation and amortization expense): | $ 27,109 | $ 32,387 | $ 52,682 | $ 71,318 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (35,214) | $ (31,889) | $ (65,087) | $ (50,193) |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustment | 3,219 | (3,730) | 802 | (14,786) |
Comprehensive loss | $ (31,995) | $ (35,619) | $ (64,285) | $ (64,979) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Treasury Stock | Accumulated Other Comprehensive Income |
Beginning balance at Dec. 31, 2019 | $ 409,538 | $ 375 | $ 747,622 | $ (317,238) | $ (56,567) | $ 35,346 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (18,304) | (18,304) | ||||
Foreign currency translation adjustment | (11,056) | (11,056) | ||||
Treasury stock purchased | (835) | (835) | ||||
Stock-based compensation, net of forfeitures | 285 | 2 | 283 | |||
Ending balance at Mar. 31, 2020 | 379,628 | 377 | 747,905 | (335,542) | (57,402) | 24,290 |
Beginning balance at Dec. 31, 2019 | 409,538 | 375 | 747,622 | (317,238) | (56,567) | 35,346 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (50,193) | |||||
Foreign currency translation adjustment | (14,786) | |||||
Ending balance at Jun. 30, 2020 | 345,120 | 378 | 749,025 | (367,431) | (57,412) | 20,560 |
Beginning balance at Mar. 31, 2020 | 379,628 | 377 | 747,905 | (335,542) | (57,402) | 24,290 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (31,889) | (31,889) | ||||
Foreign currency translation adjustment | (3,730) | (3,730) | ||||
Treasury stock purchased | (10) | (10) | ||||
Stock-based compensation, net of forfeitures | 1,121 | 1 | 1,120 | |||
Ending balance at Jun. 30, 2020 | 345,120 | 378 | 749,025 | (367,431) | (57,412) | 20,560 |
Beginning balance at Dec. 31, 2020 | 295,832 | 378 | 750,506 | (418,529) | (57,431) | 20,908 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (29,873) | (29,873) | ||||
Foreign currency translation adjustment | (2,417) | (2,417) | ||||
Treasury stock purchased | (310) | (310) | ||||
Stock-based compensation, net of forfeitures | 1,473 | 2 | 1,471 | |||
Ending balance at Mar. 31, 2021 | 264,705 | 380 | 751,977 | (448,402) | (57,741) | 18,491 |
Beginning balance at Dec. 31, 2020 | 295,832 | 378 | 750,506 | (418,529) | (57,431) | 20,908 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (65,087) | |||||
Foreign currency translation adjustment | 802 | |||||
Ending balance at Jun. 30, 2021 | 233,141 | 380 | 752,408 | (483,616) | (57,741) | 21,710 |
Beginning balance at Mar. 31, 2021 | 264,705 | 380 | 751,977 | (448,402) | (57,741) | 18,491 |
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (35,214) | (35,214) | ||||
Foreign currency translation adjustment | 3,219 | 3,219 | ||||
Stock-based compensation, net of forfeitures | 431 | 431 | ||||
Ending balance at Jun. 30, 2021 | $ 233,141 | $ 380 | $ 752,408 | $ (483,616) | $ (57,741) | $ 21,710 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Cash flows from operating activities: | ||
Net loss | $ (65,087) | $ (50,193) |
Adjustments to reconcile net loss to cash provided by operating activities: | ||
Depreciation and amortization | 88,208 | 64,257 |
Impairment | 7,959 | 0 |
Amortization of deferred financing costs | 1,330 | 1,256 |
Loss from discontinued operations, net of tax | 1,029 | 14,835 |
Provision for doubtful accounts | 825 | 3,980 |
Gain on sale of property, plant and equipment | (816) | (166) |
Gain on remeasurement of intercompany balances | (810) | (3,198) |
Loss on foreign currency derivatives | 2,030 | 0 |
Gain on extinguishment of debt | 0 | (2,644) |
Stock-based compensation expense | 1,904 | 1,406 |
Deferred income tax expense | 1,349 | 3,892 |
Changes in assets and liabilities: | ||
Accounts receivable and notes | (5,522) | (19,746) |
Inventory | 2,271 | (2,303) |
Contract assets and contract liabilities, net | (12,995) | 23,435 |
Other current assets | (144) | 3,587 |
Accounts payable and other liabilities | (11,378) | (28,878) |
Other | 870 | 13,071 |
Net cash provided by continuing operations | 11,023 | 22,591 |
Net cash used in discontinued operations | (7,993) | (11,900) |
Net cash provided by operating activities | 3,030 | 10,691 |
Cash flows from investing activities: | ||
Capital expenditures | (12,483) | (40,396) |
Proceeds from sale of property, plant and equipment | 857 | 236 |
Net cash used in continuing operations | (11,626) | (40,160) |
Net cash used in discontinued operations | 0 | (855) |
Net cash used in investing activities | (11,626) | (41,015) |
Cash flows from financing activities: | ||
Proceeds from borrowings of debt | 121,400 | 225,500 |
Repayments of debt | (110,900) | (183,316) |
Proceeds from short-term note | 1,285 | 0 |
Purchases of treasury stock (Note 11) | (310) | (845) |
Net cash provided by financing activities | 11,475 | 41,339 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (136) | (666) |
Net increase in cash, cash equivalents and restricted cash | 2,743 | 10,349 |
Cash, cash equivalents and restricted cash at beginning of period | 43,728 | 16,702 |
Cash, cash equivalents and restricted cash at end of period | 46,471 | 27,051 |
Supplemental disclosure of non-cash transactions: | ||
Accrued capital expenditures | $ 7,420 | $ 5,205 |
Description of Business and Bas
Description of Business and Basis of Presentation | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Description of Business and Basis of Presentation | Note 1 - Description of Business and Basis of Presentation Description of Business Exterran Corporation (together with its subsidiaries, “Exterran Corporation,” the “Company,” “our,” “we” or “us”), a Delaware corporation formed in March 2015, is a global sustainable systems and process company offering solutions in the oil, gas, water and power markets. We are a leader in natural gas processing and treatment, produced water treatment and compression products, solutions and services, providing critical midstream infrastructure solutions to customers throughout the world while helping them reduce their flaring, emissions and fresh water usage. We provide our products, solutions, and services to a global customer base consisting of companies engaged in all aspects of the oil and natural gas industry, including large integrated oil and natural gas companies, national oil and natural gas companies, independent oil and natural gas producers and oil and natural gas processors, gatherers and pipeline operators. Our manufacturing facilities are located in the United States of America (“U.S.”), Singapore and the United Arab Emirates. We operate in three primary business lines: contract operations, aftermarket services and product sales. In our contract operations business line, we provide processing, treating, compression and water treatment services through the operation of our natural gas and crude oil production and process equipment and natural gas compression equipment and water treatment equipment for our customers. In our aftermarket services business line, we sell parts and components and provide operations, maintenance, repair, overhaul, upgrade, startup and commissioning and reconfiguration services to customers who own their own oil and natural gas compression, production, processing, treating and related equipment. In our product sales business line, we design, engineer, manufacture, install and sell equipment used in the treating and processing of crude oil, natural gas, natural gas compression packages and water to our customers throughout the world and for use in our contract operations business line. We also offer our customers, on either a contract operations basis or a sale basis, the engineering, design, project management, procurement and construction services necessary to incorporate our products into production, processing and compression facilities, which we refer to as integrated projects. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Exterran Corporation included herein have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP are not required in these interim financial statements and have been condensed or omitted. Management believes that the information furnished includes all adjustments of a normal recurring nature that are necessary to fairly state our consolidated financial position, results of operations and cash flows for the periods indicated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2020. That report contains a comprehensive summary of our accounting policies. The interim results reported herein are not necessarily indicative of results for a full year. We refer to the consolidated financial statements collectively as “financial statements,” and individually as “balance sheets,” “statements of operations,” “statements of comprehensive income (loss),” “statements of stockholders’ equity” and “statements of cash flows” herein. In March 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption across most industries. Efforts to mitigate the spread of COVID-19 have also resulted in decreased energy demand and additional weakness in energy pricing. To help control the spread of the virus and protect the health and safety of our employees and customers, we began temporarily closing our locations or modifying operating hours in our locations around the world. This was in response to governmental requirements including “stay-at-home” orders and similar mandates and in some of our locations, we voluntarily went beyond the requirements of local government authorities. The broader implications of COVID-19 on our long-term future results of operations and overall financial condition remains uncertain. Due to the rapid market deterioration during the three months ended March 31, 2020, we concluded that a trigger existed and that we should evaluate our long-term assets for impairment. Therefore, we updated our impairment analysis and concluded that no impairment existed during the three months ended March 31, 2020. No triggering events were identified subsequent to March 31, 2020, related to the ongoing COVID-19 pandemic. Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not listed below were assessed and determined to be not applicable. Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) (“ASU 2019-12”): Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes and is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. On January 1, 2021, we adopted this update. The adoption of this update was immaterial to our financial statements. In June 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) (“ASU 2020-04”) . Topic 848 is effective for fiscal years and interim periods beginning as of March 12, 2020 through December 31, 2022. This update provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The adoption of ASU 2020-04 did not have a material impact to our financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted There are no recently issued accounting pronouncements not yet adopted that we are aware of at this time that would have a material impact on the Company. |
Revenue
Revenue | 6 Months Ended |
Jun. 30, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Note 2 - Revenue Disaggregation of Revenue The following tables present disaggregated revenue by products and services lines and by geographical regions for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, Revenue by Products and Services 2021 2020 2021 2020 Contract Operations Segment: Contract operations services (1) $ 87,498 $ 77,945 $ 168,512 $ 172,733 Aftermarket Services Segment: Operation and maintenance services (1) $ 12,474 $ 12,279 $ 24,516 $ 25,218 Part sales (2) 13,272 9,685 22,322 20,509 Other services (1) 3,655 3,029 7,683 7,175 Total aftermarket services $ 29,401 $ 24,993 $ 54,521 $ 52,902 Product Sales Segment: Compression equipment (1) (3) $ 2,646 $ 14,198 $ 7,972 $ 33,354 Processing and treating equipment (1) 22,331 8,807 43,890 20,616 Other product sales (1) (2) 4,323 5,114 7,468 12,246 Total product sales revenues $ 29,300 $ 28,119 $ 59,330 $ 66,216 Total revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 (1) Revenue recognized over time. (2) Revenue recognized at a point in time. (3) Compression equipment includes sales to customers outside of the U.S. The compression fabrication business for sales to U.S. customers that was previously included in our product sales segment is now included in discontinued operations. Three Months Ended June 30, Six Months Ended June 30, Revenue by Geographical Regions 2021 2020 2021 2020 North America $ 3,100 $ 9,354 $ 9,425 $ 18,330 Latin America 68,592 58,352 129,210 135,149 Middle East and Africa 61,979 52,373 119,158 108,086 Asia Pacific 12,528 10,978 24,570 30,286 Total revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 The North America region is primarily comprised of our operations in the U.S. The Latin America region is primarily comprised of our operations in Argentina, Bolivia, Brazil and Mexico. The Middle East and Africa region is primarily comprised of our operations in Bahrain, Iraq, Oman, Nigeria and the United Arab Emirates. The Asia Pacific region is primarily comprised of our operations in China, Indonesia, Singapore and Thailand. The following table summarizes the expected timing of revenue recognition from unsatisfied performance obligations (commonly referred to as backlog) as of June 30, 2021 (in thousands): Contract Operations Segment Product Sales Segment Remainder of 2021 $ 148,930 $ 132,010 2022 216,340 205,073 2023 207,066 43,670 2024 191,391 12,480 2025 170,595 17,557 Thereafter 252,621 — Total backlog $ 1,186,943 $ 410,790 Certain of our aftermarket services contracts are subject to cancellation or modification at the election of the customer. If the primary component of our contract operations contracts is the lease component, the contracts are accounted for as operating leases. For these contracts, revenues are recognized on a straight-line basis. As of June 30, 2021, the total value of our contracts operations backlog accounted for as operating leases was approximately $331.8 million, of which $19 million is expected to be recognized in the remainder of 2021, $44 million is expected to be recognized in 2022, $87 million is expected to be recognized in 2023, $76 million is expected to be recognized in 2024 and $61 million is expected to be recognized in 2025. Contract operations revenue recognized as operating leases for the six months ended June 30, 2021 was approximately $18 million. Our product sales backlog includes contracts where there is a significant financing component. As of June 30, 2021, we had approximately $43 million expected to be recognized in future periods as interest income within our product sales segment. Contract Assets and Contract Liabilities The following table provides information about accounts receivables, net, contract assets and contract liabilities from contracts with customers (in thousands): June 30, 2021 December 31, 2020 Accounts receivables, net $ 202,899 $ 198,028 Contract assets and contract liabilities: Current contract assets 32,528 32,642 Long-term contract assets 17,537 33,563 Current contract liabilities 94,669 100,123 Long-term contract liabilities 69,804 80,499 During the six months ended June 30, 2021, revenue recognized from contract operations services included $35.5 million of revenue deferred in previous periods. Revenue recognized during the six months ended June 30, 2021 from product sales performance obligations partially satisfied in previous periods was $50.8 million, of which $27.7 million was included in billings in excess of costs at the beginning of the period. The decrease in long-term contract assets during the six months ended June 30, 2021 was primarily due to the timing of milestones billings in the Middle East and Africa region. The decrease in current contract liabilities during the six months ended June 30, 2021 was primarily driven by the progression of product sales projects and the timing of milestones billings in the Middle East and Africa region. The decrease in long-term contract liabilities during the six months ended June 30, 2021 was primarily driven by the acceleration of deferred revenue on two separate contracts due to a change in the terms in the Latin America region. Allowance for Doubtful Accounts The Company estimates its reserves using information about past events, current conditions and risk characteristics of each customer, and reasonable and supportable forecasts relevant to assessing risk associated with the collectability of accounts receivables, contract assets and long-term note receivables. The Company’s customer base has generally similar collectability risk characteristics, although larger customers may have lower risk than smaller independent customers. The allowance for doubtful accounts as of June 30, 2021 and changes for the three months then ended are as follows (in thousands): Balance at December 31, 2020 $ 10,803 Write-offs during the period (496) Balance at June 30, 2021 $ 10,307 |
Discontinued Operations
Discontinued Operations | 6 Months Ended |
Jun. 30, 2021 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Discontinued Operations | Note 3 - Discontinued Operations We have continued to work toward our strategy to be a company that leverages technology and operational excellence to provide complete systems and process solutions in energy and industrial applications. Over the past several years, we have made significant progress in this journey by taking actions to protect our core business, develop important organizational capabilities, commercialize new products, solutions, and services and implement new processes to position Exterran for success. We are focused on optimizing our portfolio of products and services to better serve our global customers while providing a more attractive investment option for our investors. As we continue on this path, we decided that our U.S. compression fabrication business was non-core to our strategy, and during the third quarter of 2020, we entered into an agreement to sell the assets used to operate the business which closed on November 2, 2020. We did not sell certain items in inventory, which we expect to liquidate over time. During the third quarter of 2020, this business met the held for sale criteria and is now reflected as discontinued operations in our financial statements for all periods presented. The U.S. compression fabrication business was previously included in our product sales segment and has been reclassified to discontinued operations in our financial statements for all periods presented. Compression revenue from sales to international customers continues to be included in our product sales segment. In addition, in connection with our review of options for the U.S. compression fabrication business, we reviewed the assets in this business compared to our estimate of future cash flows and recorded impairments of $6.5 million during the three and six months ended June 30, 2020 to adjust the carrying value to our estimate of fair market value. In the first quarter of 2016, we began executing the exit of our Belleli EPC business that has historically been comprised of engineering, procurement and construction for the manufacture of tanks for tank farms and the manufacture of evaporators and brine heaters for desalination plants in the Middle East (referred to as “Belleli EPC” or the “Belleli EPC business” herein) by ceasing the bookings of new orders. As of the fourth quarter of 2017, we had substantially exited our Belleli EPC business and, in accordance with GAAP, it is reflected as discontinued operations in our financial statements for all periods presented. Although we have reached mechanical completion on all remaining Belleli EPC contracts, we are still subject to risks and uncertainties potentially resulting from warranty obligations, customer or supplier claims against us, settlement of claims against customers, completion of demobilization activities and litigation developments. The facility previously utilized to manufacture products for our Belleli EPC business has been repurposed to manufacture product sales equipment. As such, certain personnel, buildings, equipment and other assets that were previously related to our Belleli EPC business remain a part of our continuing operations. As a result, activities associated with our ongoing operations at our repurposed facility are included in continuing operations. The following table summarizes the operating results of discontinued operations (in thousands): Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Revenue $ — $ — $ — $ — $ 40,568 $ 40,568 Cost of sales (excluding depreciation and amortization expense) — (37) (37) 88 38,437 38,525 Selling, general and administrative 86 18 104 101 2,864 2,965 Depreciation and amortization — — — — 665 665 Impairments — — — — 6,512 6,512 Restructuring and other charges — — — — 4,572 4,572 Other expense, net — 59 59 5 — 5 Provision for (benefit from) income taxes 30 — 30 (72) — (72) Loss from discontinued operations, net of tax $ (116) $ (40) $ (156) $ (122) $ (12,482) $ (12,604) Six Months Ended June 30, 2021 Six Months Ended June 30, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Revenue $ — $ 53 $ 53 $ 124 $ 90,131 $ 90,255 Cost of sales (excluding depreciation and amortization expense) 55 172 227 184 83,945 84,129 Selling, general and administrative 244 413 657 214 7,356 7,570 Depreciation and amortization — — — — 1,324 1,324 Impairments — — — — 6,512 6,512 Restructuring and other charges — — — — 5,553 5,553 Other expense, net 34 59 93 49 — 49 Provision for (benefit from) income taxes 105 — 105 (47) — (47) Loss from discontinued operations, net of tax $ (438) $ (591) $ (1,029) $ (276) $ (14,559) $ (14,835) The following table summarizes the balance sheet data for discontinued operations (in thousands): June 30, 2021 December 31, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Accounts receivable $ 268 $ 101 $ 369 $ 268 $ 3,171 $ 3,439 Inventory — 21,006 21,006 — 21,107 21,107 Contract assets — 247 247 — 458 458 Other current assets 173 — 173 213 108 321 Total current assets associated with discontinued operations 441 21,354 21,795 481 24,844 25,325 Intangible and other assets, net 1,687 — 1,687 1,606 — 1,606 Total assets associated with discontinued operations $ 2,128 $ 21,354 $ 23,482 $ 2,087 $ 24,844 $ 26,931 Accounts payable $ 35 $ 641 $ 676 $ 139 $ 5,093 $ 5,232 Accrued liabilities 2,752 519 3,271 2,939 5,037 7,976 Contract liabilities 197 25 222 197 302 499 Total current liabilities associated with discontinued operations 2,984 1,185 4,169 3,275 10,432 13,707 Other long-term liabilities 982 285 1,267 765 1,377 2,142 Total liabilities associated with discontinued operations $ 3,966 $ 1,470 $ 5,436 $ 4,040 $ 11,809 $ 15,849 |
Inventory
Inventory | 6 Months Ended |
Jun. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Inventory | Note 4 - Inventory Inventory consisted of the following amounts (in thousands): June 30, 2021 December 31, 2020 Parts and supplies $ 65,626 $ 65,576 Work in progress 38,921 41,020 Finished goods 3,241 3,241 Inventory $ 107,788 $ 109,837 |
Property, Plant and Equipment,
Property, Plant and Equipment, Net | 6 Months Ended |
Jun. 30, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, Net | Note 5 - Property, Plant and Equipment, Net Property, plant and equipment, net, consisted of the following (in thousands): June 30, 2021 December 31, 2020 Compression equipment, processing facilities and other fleet assets (1) $ 1,559,397 $ 1,562,528 Land and buildings 50,975 50,908 Transportation and shop equipment 53,712 54,763 Computer software 55,495 54,486 Other 43,029 40,305 1,762,608 1,762,990 Accumulated depreciation (1,099,471) (1,029,768) Property, plant and equipment, net $ 663,137 $ 733,222 (1) In the first quarter of 2021, we evaluated the salvage values of our property, plant and equipment. As a result of this evaluation, we changed the salvage values for our compression equipment to a maximum salvage value of 5% from 15%. During the three and six months ended June 30, 2021, we recorded an increase to depreciation expense of approximately $1.2 million and $2.1 million, respectively as a result of this change in salvage value. |
Debt
Debt | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Debt | Note 6 - Debt Debt consisted of the following (in thousands): June 30, 2021 December 31, 2020 Revolving credit facility due October 2023 $ 227,000 $ 216,500 8.125% senior notes due May 2025 350,000 350,000 Other 1,285 — Unamortized deferred financing costs of 8.125% senior notes (3,693) (4,175) Total debt 574,592 562,325 Less: Amounts within one year (1) (1,285) — Long-term debt $ 573,307 $ 562,325 (1) Short-term debt and the current portion of long-term debt are included in accrued liabilities in our balance sheets. Revolving Credit Facility Due October 2023 We and our wholly owned subsidiary, Exterran Energy Solutions, L.P. (“EESLP”), are parties to an amended and restated credit agreement (the “Amended Credit Agreement”) consisting of a $650.0 million revolving credit facility expiring in October 2023. As of June 30, 2021, we had $227.0 million in outstanding borrowings and $28.0 million in outstanding letters of credit under our revolving credit facility. At June 30, 2021, taking into account guarantees through letters of credit, we had undrawn capacity of $395.0 million under our revolving credit facility. Our Amended Credit Agreement limits our Total Debt to EBITDA ratio (as defined in the Amended Credit Agreement) on the last day of the fiscal quarter to no greater than 4.50 to 1.0. As a result of this limitation, $147.8 million of the $395.0 million of undrawn capacity under our revolving credit facility was available for additional borrowings as of June 30, 2021. 8.125% Senior Notes Due May 2025 In April 2017, our 100% owned subsidiaries EESLP and EES Finance Corp. issued $375.0 million aggregate principal amount of 8.125% senior unsecured notes due 2025 (the “2017 Notes”) which have $350.0 million outstanding as of June 30, 2021. We guarantee the 2017 Notes on a senior unsecured basis. We may redeem the 2017 Notes at any time in cash, in whole or part, at certain redemption prices, including the applicable make-whole premium plus accrued and unpaid interest, if any, to the date of redemption. During the second quarter of 2020, we purchased and retired $19.0 million principal amount of our 2017 Notes for $16.3 million (including $0.2 million of accrued interest) resulting in a gain on extinguishment of debt of $2.6 million. The gain was calculated as the difference between the repurchase price and the carrying amount of the 2017 Notes, partially offset by $0.2 million in related deferred financing costs. The gain on extinguishment of debt is included as a separate item in our statements of operations. During July 2020, we purchased and retired an additional $5.0 million of our 2017 Notes for $4.3 million including $0.1 million of accrued interest. The Amended Credit Agreement contains various covenants with which we, EESLP and our respective restricted subsidiaries must comply, including, but not limited to, limitations on the incurrence of indebtedness, investments, liens on assets, repurchasing equity, making distributions, transactions with affiliates, mergers, consolidations, dispositions of assets and other provisions customary in similar types of agreements. We are required to maintain, on a consolidated basis, a minimum interest coverage ratio (as defined in the Amended Credit Agreement) of 2.25 to 1.00; a maximum total leverage ratio (as defined in the Amended Credit Agreement) of 4.50 to 1.00; and a maximum senior secured leverage ratio (as defined in the Amended Credit Agreement) of 2.75 to 1.00. As of June 30, 2021, we maintained a 5.7 to 1.0 interest coverage ratio, a 3.6 to 1.0 total leverage ratio and a 1.4 to 1.0 senior secured leverage ratio. As of June 30, 2021, we were in compliance with all financial covenants under the Amended Credit Agreement. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 7 - Fair Value Measurements The accounting standard for fair value measurements and disclosures establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into the following three categories: • Level 1 — Quoted unadjusted prices for identical instruments in active markets to which we have access at the date of measurement. • Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 2 inputs are those in markets for which there are few transactions, the prices are not current, little public information exists or prices vary substantially over time or among brokered market makers. • Level 3 — Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. Unobservable inputs are those inputs that reflect our own assumptions regarding how market participants would price the asset or liability based on the best available information. Recurring Fair Value Measurements The following table presents our assets and liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020, with pricing levels as of the date of valuation (in thousands): June 30, 2021 December 31, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Foreign currency derivatives liabilities $ — $ — $ — $ — $ — $ (247) We are exposed to market risks associated with changes in foreign currency exchange rates, including foreign currency exchange rate changes recorded on intercompany obligations. From time to time, we may enter into foreign currency hedges to manage existing exposures to foreign exchange risk related to assets and liabilities recorded on our balance sheets including intercompany activity. During the three and six months ended June 30, 2021, we recognized a loss of $1.1 million and $2.0 million, respectively on forward currency exchange contracts. As of June 30, 2021, we do not have derivative financial instruments outstanding to mitigate foreign currency risk. Nonrecurring Fair Value Measurements The following table presents our assets and liabilities measured at fair value on a nonrecurring basis during the six months ended June 30, 2021 and 2020, with pricing levels as of the date of valuation (in thousands): Six months ended June 30, 2021 Six months ended June 30, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Impaired long-lived assets (1) $ — $ — $ — $ — $ — $ — Long-term note receivable (2) — — 12,119 — — 15,039 (1) Our estimate of the fair value of the impaired long-lived assets as of June 30, 2021, were primarily based on the expectation that these assets are unlikely to generate future cash flows either through continuation of this contract or through proceeds from the sale of the assets and thus they were written down to zero. (2) Our estimate of the fair value of a note receivable was discounted based on a settlement period of eight years and a discount rate of 12.5%. The undiscounted value of the note receivable, including interest, as of June 30, 2021 was $15.7 million. Financial Instruments Our financial instruments consist of cash, restricted cash, receivables, payables and debt. At June 30, 2021 and December 31, 2020, the estimated fair values of cash, restricted cash, receivables and payables approximated their carrying amounts as reflected in our balance sheets due to the short-term nature of these financial instruments. The fair value of the 2017 Notes was estimated based on model derived calculations using market yields observed in active markets, which are Level 2 inputs. As of June 30, 2021 and December 31, 2020, the carrying amount of the 2017 Notes, excluding unamortized deferred financing costs, of $350.0 million was estimated to have a fair value of $312.0 million and $297.0 million, respectively. Due to the variable rate nature of our revolving credit facility, the carrying value as of June 30, 2021 and December 31, 2020 approximated the fair value as the rate was comparable to the then-current market rate at which debt with similar terms could have been obtained. |
Impairments
Impairments | 6 Months Ended |
Jun. 30, 2021 | |
Asset Impairment Charges [Abstract] | |
Impairments | Note 8 - Impairments We review long-lived assets, including property, plant and equipment and identifiable intangibles that are being amortized, for impairment whenever events or changes in circumstances, indicate that the carrying amount of an asset may not be recoverable. During the three months ended March 31, 2021, there were no events, or changes in circumstances to indicate that the carrying amount of an asset may not be recoverable. During the three months ended June 30, 2021, we determined that there was no visibility to continuing a contract with a customer in the Latin America region. This contract included installation costs, deferred start-up costs and demobilization costs that were previously capitalized where it is highly unlikely we will generate future cash flows. As a result, during the three and six months ended June 30, 2021, we recorded an $8.0 million asset impairment to reduce the book value of these assets to zero, which is its estimated fair value as of June 30, 2021. |
Restructuring and Other Charges
Restructuring and Other Charges | 6 Months Ended |
Jun. 30, 2021 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Charges | Note 9 - Restructuring and Other Charges The energy industry’s focus on cash flow, capital discipline and improving returns has caused delays in the timing of new equipment orders. As a result, in the third quarter of 2019, we announced a cost reduction plan primarily focused on workforce reductions. During the three months ended June 30, 2021, we released an unused portion of previously expensed restructuring charges of $0.4 million and during the three months ended June 30, 2020, we incurred restructuring and other charges associated with these activities of $3.1 million. During the six months ended June 30, 2021 and 2020, we incurred restructuring and other charges associated with these activities of $0.3 million and $3.3 million, respectively. These charges are reflected as restructuring and other charges in our statements of operations and accrued liabilities on our balance sheets. The cost reduction plan is expected to be completed in the third quarter of 2021 and we expect to settle these charges in cash. The following table summarizes the changes to our accrued liability balance related to restructuring and other charges for the six months ended June 30, 2021 and 2020 (in thousands): Cost Beginning balance at January 1, 2020 $ 2,281 Additions for costs expensed, net 3,312 Reductions for payments (1,050) Foreign exchange impact (404) Ending balance at June 30, 2020 $ 4,139 Beginning balance at January 1, 2021 $ 1,351 Additions for costs expensed, net 254 Reductions for payments (1,317) Foreign exchange impact 51 Ending balance at June 30, 2021 $ 339 The following table summarizes the components of charges included in restructuring and other charges in our statements of operations for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Employee termination benefits $ (441) $ 741 $ 183 $ 741 Legal fees 71 — 71 — Consulting fees — 2,364 — 2,571 Total restructuring and other charges $ (370) $ 3,105 $ 254 $ 3,312 The following table summarizes the components of charges included in restructuring and other charges incurred since the announcement of the cost reduction plan in the second quarter of 2019 (in thousands): Total Employee termination benefits $ 6,426 Legal fees 71 Consulting fees 3,205 Total restructuring and other charges $ 9,702 |
Provision for Income Taxes
Provision for Income Taxes | 6 Months Ended |
Jun. 30, 2021 | |
Income Tax Disclosure [Abstract] | |
Provision for Income Taxes | Note 10 - Provision for Income Taxes Our effective tax rate is affected by recurring items, such as tax rates in foreign jurisdictions and the relative amounts of income we earn, or losses we incur, in those jurisdictions. It is also affected by discrete items that may occur in any given year but are not consistent from year to year. Our effective tax rate is also affected by valuation allowances recorded against loss carryforwards in the U.S. and certain other jurisdictions, foreign withholding taxes and changes in foreign currency exchange rates. The following items had the most significant impact on the difference between our statutory U.S. federal income tax rate of 21% and our effective tax rate of (33.7)% for the three months ended June 30, 2021: (i) a (5.7)% negative impact resulting from unrecognized tax benefits under FASB’s Interpretation No. 48 of Financial Accounting Standard 109 (“FIN 48”), (ii) a (10.9)% negative impact resulting from foreign currency devaluations in Argentina, (iii) a (19.6)% negative impact resulting from foreign taxes in excess of the U.S. tax rate and other rate drivers, (iv) an (11.6)% negative impact resulting from deemed inclusions in the U.S. and (v) a (4.1)% negative impact resulting from an addition of valuation allowances against U.S. deferred tax assets. The following items had the most significant impact on the difference between our statutory U.S. federal income tax rate of 21% and our effective tax rate of (34.1)% for the six months ended June 30, 2021: (i) an (11.5)% negative impact resulting from foreign currency devaluations in Argentina, (ii) a (19.9)% negative impact resulting from foreign taxes in excess of the U.S. tax rate and other rate drivers, (iii) a (12.0)% negative impact resulting from deemed inclusions in the U.S. and (iv) a (6.6)% negative impact resulting from an addition of valuation allowances against U.S. deferred tax assets. Our effective tax rate increased for the six months ended June 30, 2021 compared to the six months ended June 30, 2020 primarily due to a decrease in valuation allowances recorded in the U.S., an increase in foreign taxes in excess of the U.S. tax rate, an increase in deemed inclusions in the U.S., a decrease in the FIN 48 reserve and an increase in tax related to foreign exchange movement in Argentina. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2021 | |
Equity [Abstract] | |
Stockholders' Equity | Note 11 - Stockholders’ Equity Share Repurchase Program On February 20, 2019, our board of directors approved a share repurchase program under which the Company is authorized to purchase up to $100.0 million of its outstanding common stock through February 2022. The timing and method of any repurchases under the program will depend on a variety of factors, including prevailing market conditions among others. Purchases under the program may be suspended or discontinued at any time and we have no obligation to repurchase any amount of our common shares under the program. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the six months ended June 30, 2021 and 2020, we did not repurchase any shares under this program. As of June 30, 2021, the remaining authorized repurchase amount under the share repurchase program was $57.7 million. Additionally, treasury stock purchased during the six months ended June 30, 2021 and 2020 included shares withheld to satisfy employees’ tax withholding obligations in connection with vesting of restricted stock awards. |
Stock-Based Compensation
Stock-Based Compensation | 6 Months Ended |
Jun. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Note 12 - Stock-Based Compensation Stock Options There were no stock options granted during the six months ended June 30, 2021 and 2020. Restricted Stock, Restricted Stock Units and Performance Units For grants of restricted stock, restricted stock units and performance units, we recognize compensation expense over the applicable vesting period equal to the fair value of our common stock at the grant date. Grants of restricted stock, restricted stock units and performance units generally vest over two The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the six months ended June 30, 2021. Equity Awards Liability Awards Shares Weighted Average Shares Weighted Average Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 211 4.78 1,418 4.84 Vested (281) 13.16 (371) 14.02 Cancelled (10) 17.45 (47) 6.08 Non-vested awards, June 30, 2021 240 9.43 2,198 5.72 As of June 30, 2021, we estimate $8.4 million of unrecognized compensation cost related to unvested restricted stock, restricted stock units and performance units issued to our employees to be recognized over the weighted-average vesting period of 1.4 years. |
Net Income (Loss) Per Common Sh
Net Income (Loss) Per Common Share | 6 Months Ended |
Jun. 30, 2021 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) Per Common Share | Note 13 - Net Income (Loss) Per Common Share Basic net income (loss) per common share is computed using the two-class method, which is an earnings allocation formula that determines net income (loss) per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. Under the two-class method, basic net income (loss) per common share is determined by dividing net income (loss) after deducting amounts allocated to participating securities, by the weighted average number of common shares outstanding for the period. Participating securities include unvested restricted stock and restricted stock units that have non-forfeitable rights to receive dividends or dividend equivalents, whether paid or unpaid. During periods of net loss from continuing operations, no effect is given to participating securities because they do not have a contractual obligation to participate in our losses. Diluted net income (loss) per common share is computed using the weighted average number of common shares outstanding adjusted for the incremental common stock equivalents attributed to outstanding options to purchase common stock and non-participating restricted stock units, unless their effect would be anti-dilutive. The following table presents a reconciliation of basic and diluted net loss per common share for the three and six months ended June 30, 2021 and 2020 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2021 2020 2021 2020 Numerator for basic and diluted net loss per common share: Loss from continuing operations $ (35,058) $ (19,285) $ (64,058) $ (35,358) Loss from discontinued operations, net of tax (156) (12,604) (1,029) (14,835) Less: Net income attributable to participating securities — — — — Net loss — used in basic and diluted net loss per common share $ (35,214) $ (31,889) $ (65,087) $ (50,193) Weighted average common shares outstanding including participating securities 33,350 33,175 33,289 33,161 Less: Weighted average participating securities outstanding (294) (372) (286) (441) Weighted average common shares outstanding — used in basic net loss per common share 33,056 32,803 33,003 32,720 Net dilutive potential common shares issuable: On exercise of options and vesting of restricted stock units * * * * Weighted average common shares outstanding — used in diluted net loss per common share 33,056 32,803 33,003 32,720 Net loss per common share: Basic and diluted $ (1.07) $ (0.97) $ (1.97) $ (1.53) * Excluded from diluted net income (loss) per common share as their inclusion would have been anti-dilutive. The following table shows the potential shares of common stock issuable for the three and six months ended June 30, 2021 and 2020 that were excluded from computing diluted net loss per common share as their inclusion would have been anti-dilutive (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2021 2020 2021 2020 Net dilutive potential common shares issuable: On exercise of options where exercise price is greater than average market value — 30 — 43 Net dilutive potential common shares issuable — 30 — 43 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 14 - Commitments and Contingencies Contingencies We have agreements with financial institutions under which approximately $59.4 million of letters of credit or bank guarantees were outstanding as of June 30, 2021. These are put in place in certain situations to guarantee our performance obligations under contracts with counterparties. In addition to U.S. federal, state and local and foreign income taxes, we are subject to a number of taxes that are not income-based. As many of these taxes are subject to audit by the taxing authorities, it is possible that an audit could result in additional taxes due. We accrue for such additional taxes when we determine that it is probable that we have incurred a liability and we can reasonably estimate the amount of the liability. As of June 30, 2021 and December 31, 2020, we had accrued $1.5 million and $3.5 million, respectively, for the outcomes of non-income-based tax audits. We do not expect that the ultimate resolutions of these audits will result in a material variance from the amounts accrued. We do not accrue for unasserted claims for tax audits unless we believe the assertion of a claim is probable, it is probable that it will be determined that the claim is owed and we can reasonably estimate the claim or range of the claim. We do not have any unasserted claims from non-income based tax audits that we have determined are probable of assertion. We also believe the likelihood is remote that the impact of potential unasserted claims from non-income-based tax audits could be material to our financial position, but it is possible that the resolution of future audits could be material to our results of operations or cash flows for the period in which the resolution occurs. Our business can be hazardous, involving unforeseen circumstances such as uncontrollable flows of natural gas or well fluids and fires or explosions. As is customary in our industry, we review our safety equipment and procedures and carry insurance against some, but not all, risks of our business. Our insurance coverage includes property damage, general liability, commercial automobile liability and other coverage we believe is appropriate. We believe that our insurance coverage is customary for the industry and adequate for our business; however, losses and liabilities not covered by insurance would increase our costs. Additionally, we are substantially self-insured for workers’ compensation and employee group health claims in view of the relatively high per-incident deductibles we absorb under our insurance arrangements for these risks. Losses up to the deductible amounts are estimated and accrued based upon known facts, historical trends and industry averages. Litigation and Claims On December 19, 2020, we initiated arbitration in the International Court of Arbitration of the International Chamber of Commerce (“ICC”) against Iberoamericana de Hidrocarburos, S.A. De C.V. (“IHSA”) to collect approximately $38 million owed to us under three agreements, plus future lost profits, interest, attorneys’ fees, and other damages as allowed under the contracts and/or Mexican law. The three agreements relate to contract operation services provided to IHSA by Exterran. After we stopped providing services due to IHSA’s nonpayment, on December 29, 2020, IHSA filed a lawsuit in the 129th Judicial District Court of Harris County, Texas, for tortious interference with a contract and prospective business relationships, claiming damages for lost profits, lost production, loss of equipment, loss of business opportunity, damage to business reputation and attorneys’ fees. On March 2, 2021, after we moved IHSA’s lawsuit to the United States District Court for the Southern District of Texas, IHSA voluntarily dismissed the lawsuit. On May 11, 2021, IHSA again filed a similar claim in the 164th Judicial District Court of Harris County, Texas, for tortious interference with a contract and prospective business relationships, seeking damages in excess of $1 million. We moved IHSA’s lawsuit to the United States District Court for the Southern District of Texas, where it is currently pending. On April 27, 2021, IHSA also answered Exterran’s request for arbitration before the ICC and included a counterclaim for approximately $27 million allegedly resulting from breach of contract, operational deficiencies, lost production, and lost profit. In addition, IHSA has orally threatened to draw certain bonds totaling approximately $12 million under one of the contracts for contract operation services. Based on currently available information we believe IHSA’s claims are without merit; however, IHSA’s claim are in the early stages and the results cannot be predicted with certainty. On July 5, 2021, Inesco Ingenieria & Construccion, S.A. (“Inesco”) filed a Demand for Arbitration in the ICC against Exterran Bolivia S.R.L. claiming it is owed approximately $13 million for certain goods and services allegedly provided to Exterran, delay damages, and increased expenses. Based on currently available information we believe Inesco’s claims are without merit; however, Inesco’s claims are in the early stages and the results cannot be predicted with certainty. |
Reportable Segments
Reportable Segments | 6 Months Ended |
Jun. 30, 2021 | |
Segment Reporting [Abstract] | |
Reportable Segments | Note 15 - Reportable Segments Our chief operating decision maker manages business operations, evaluates performance and allocates resources based upon the type of product or service provided. We have three reportable segments: contract operations, aftermarket services and product sales. In our contract operations segment, we provide processing, treating, compression and water treatment services through the operation of our natural gas and crude oil production and process equipment, natural gas compression equipment and water treatment equipment for our customers. In our aftermarket services segment, we sell parts and components and provide operations, maintenance, repair, overhaul, upgrade, startup and commissioning and reconfiguration services to customers who own their own oil and natural gas compression, production, processing, treating and related equipment. In our product sales segment, we design, engineer, manufacture, install and sell equipment used in the treating and processing of crude oil, natural gas and water as well natural gas compression packages to our customers throughout the world and for use in our contract operations business line. We evaluate the performance of our segments based on adjusted gross margin for each segment. Revenue only includes sales to external customers. We do not include intersegment sales when we evaluate our segments’ performance. The following table presents revenue and other financial information by reportable segment for the three and six months ended June 30, 2021 and 2020 (in thousands): Three months ended June 30, Contract Aftermarket Product sales (2) Reportable 2021 Revenue $ 87,498 $ 29,401 $ 29,300 $ 146,199 Adjusted gross margin (1) 59,734 5,979 2,191 67,904 2020 Revenue $ 77,945 $ 24,993 $ 28,119 $ 131,057 Adjusted gross margin (1) 54,199 5,973 (4,268) 55,904 Six months ended June 30, Contract Aftermarket Product sales (2) Reportable 2021 Revenue $ 168,512 $ 54,521 $ 59,330 $ 282,363 Adjusted gross margin (1) 117,404 11,087 6,648 135,139 2020 Revenue $ 172,733 $ 52,902 $ 66,216 $ 291,851 Adjusted gross margin (1) 117,527 12,701 (5,102) 125,126 (1) Adjusted gross margin is defined as revenue less cost of sales (excluding depreciation and amortization expense). (2) The U.S. compression fabrication business that was previously included in our product sales segment is now included in discontinued operations. The following table reconciles total gross margin to total adjusted gross margin (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 Cost of sales (excluding depreciation and amortization expenses) 78,295 75,153 147,224 166,725 Depreciation and amortization (1) 44,017 30,861 84,852 61,307 Total gross margin 23,887 25,043 50,287 63,819 Depreciation and amortization (1) 44,017 30,861 84,852 61,307 Total adjusted gross margin $ 67,904 $ 55,904 $ 135,139 $ 125,126 (1) Represents the portion only attributable to cost of sales. |
Description of Business and B_2
Description of Business and Basis of Presentation (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Exterran Corporation included herein have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP are not required in these interim financial statements and have been condensed or omitted. Management believes that the information furnished includes all adjustments of a normal recurring nature that are necessary to fairly state our consolidated financial position, results of operations and cash flows for the periods indicated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the year ended December 31, 2020. That report contains a comprehensive summary of our accounting policies. The interim results reported herein are not necessarily indicative of results for a full year. We refer to the consolidated financial statements collectively as “financial statements,” and individually as “balance sheets,” “statements of operations,” “statements of comprehensive income (loss),” “statements of stockholders’ equity” and “statements of cash flows” herein. In March 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption across most industries. Efforts to mitigate the spread of COVID-19 have also resulted in decreased energy demand and additional weakness in energy pricing. To help control the spread of the virus and protect the health and safety of our employees and customers, we began temporarily closing our locations or modifying operating hours in our locations around the world. This was in response to governmental requirements including “stay-at-home” orders and similar mandates and in some of our locations, we voluntarily went beyond the requirements of local government authorities. The broader implications of COVID-19 on our long-term future results of operations and overall financial condition remains uncertain. Due to the rapid market deterioration during the three months ended March 31, 2020, we concluded that a trigger existed and that we should evaluate our long-term assets for impairment. Therefore, we updated our impairment analysis and concluded that no impairment existed during the three months ended March 31, 2020. No triggering events were identified subsequent to March 31, 2020, related to the ongoing COVID-19 pandemic. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not listed below were assessed and determined to be not applicable. Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) (“ASU 2019-12”): Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes and is effective for annual and interim periods beginning after December 15, 2020, with early adoption permitted. On January 1, 2021, we adopted this update. The adoption of this update was immaterial to our financial statements. In June 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) (“ASU 2020-04”) . Topic 848 is effective for fiscal years and interim periods beginning as of March 12, 2020 through December 31, 2022. This update provides optional guidance for a limited period of time to ease the potential burden in accounting for reference rate reform on financial reporting. It is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The adoption of ASU 2020-04 did not have a material impact to our financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted There are no recently issued accounting pronouncements not yet adopted that we are aware of at this time that would have a material impact on the Company. |
Revenue (Tables)
Revenue (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following tables present disaggregated revenue by products and services lines and by geographical regions for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, Revenue by Products and Services 2021 2020 2021 2020 Contract Operations Segment: Contract operations services (1) $ 87,498 $ 77,945 $ 168,512 $ 172,733 Aftermarket Services Segment: Operation and maintenance services (1) $ 12,474 $ 12,279 $ 24,516 $ 25,218 Part sales (2) 13,272 9,685 22,322 20,509 Other services (1) 3,655 3,029 7,683 7,175 Total aftermarket services $ 29,401 $ 24,993 $ 54,521 $ 52,902 Product Sales Segment: Compression equipment (1) (3) $ 2,646 $ 14,198 $ 7,972 $ 33,354 Processing and treating equipment (1) 22,331 8,807 43,890 20,616 Other product sales (1) (2) 4,323 5,114 7,468 12,246 Total product sales revenues $ 29,300 $ 28,119 $ 59,330 $ 66,216 Total revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 (1) Revenue recognized over time. (2) Revenue recognized at a point in time. (3) Compression equipment includes sales to customers outside of the U.S. The compression fabrication business for sales to U.S. customers that was previously included in our product sales segment is now included in discontinued operations. Three Months Ended June 30, Six Months Ended June 30, Revenue by Geographical Regions 2021 2020 2021 2020 North America $ 3,100 $ 9,354 $ 9,425 $ 18,330 Latin America 68,592 58,352 129,210 135,149 Middle East and Africa 61,979 52,373 119,158 108,086 Asia Pacific 12,528 10,978 24,570 30,286 Total revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 |
Schedule of Expected Timing of Revenue Recognition from Unsatisfied Performance Obligation | The following table summarizes the expected timing of revenue recognition from unsatisfied performance obligations (commonly referred to as backlog) as of June 30, 2021 (in thousands): Contract Operations Segment Product Sales Segment Remainder of 2021 $ 148,930 $ 132,010 2022 216,340 205,073 2023 207,066 43,670 2024 191,391 12,480 2025 170,595 17,557 Thereafter 252,621 — Total backlog $ 1,186,943 $ 410,790 |
Contract with Customer, Asset and Liability | The following table provides information about accounts receivables, net, contract assets and contract liabilities from contracts with customers (in thousands): June 30, 2021 December 31, 2020 Accounts receivables, net $ 202,899 $ 198,028 Contract assets and contract liabilities: Current contract assets 32,528 32,642 Long-term contract assets 17,537 33,563 Current contract liabilities 94,669 100,123 Long-term contract liabilities 69,804 80,499 |
Allowance for Doubtful Accounts | The allowance for doubtful accounts as of June 30, 2021 and changes for the three months then ended are as follows (in thousands): Balance at December 31, 2020 $ 10,803 Write-offs during the period (496) Balance at June 30, 2021 $ 10,307 |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Summary of Operating Results and Balance Sheet Data for Discontinued Operations and Disposals | The following table summarizes the operating results of discontinued operations (in thousands): Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Revenue $ — $ — $ — $ — $ 40,568 $ 40,568 Cost of sales (excluding depreciation and amortization expense) — (37) (37) 88 38,437 38,525 Selling, general and administrative 86 18 104 101 2,864 2,965 Depreciation and amortization — — — — 665 665 Impairments — — — — 6,512 6,512 Restructuring and other charges — — — — 4,572 4,572 Other expense, net — 59 59 5 — 5 Provision for (benefit from) income taxes 30 — 30 (72) — (72) Loss from discontinued operations, net of tax $ (116) $ (40) $ (156) $ (122) $ (12,482) $ (12,604) Six Months Ended June 30, 2021 Six Months Ended June 30, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Revenue $ — $ 53 $ 53 $ 124 $ 90,131 $ 90,255 Cost of sales (excluding depreciation and amortization expense) 55 172 227 184 83,945 84,129 Selling, general and administrative 244 413 657 214 7,356 7,570 Depreciation and amortization — — — — 1,324 1,324 Impairments — — — — 6,512 6,512 Restructuring and other charges — — — — 5,553 5,553 Other expense, net 34 59 93 49 — 49 Provision for (benefit from) income taxes 105 — 105 (47) — (47) Loss from discontinued operations, net of tax $ (438) $ (591) $ (1,029) $ (276) $ (14,559) $ (14,835) The following table summarizes the balance sheet data for discontinued operations (in thousands): June 30, 2021 December 31, 2020 Belleli EPC US Compression Total Belleli EPC US Compression Total Accounts receivable $ 268 $ 101 $ 369 $ 268 $ 3,171 $ 3,439 Inventory — 21,006 21,006 — 21,107 21,107 Contract assets — 247 247 — 458 458 Other current assets 173 — 173 213 108 321 Total current assets associated with discontinued operations 441 21,354 21,795 481 24,844 25,325 Intangible and other assets, net 1,687 — 1,687 1,606 — 1,606 Total assets associated with discontinued operations $ 2,128 $ 21,354 $ 23,482 $ 2,087 $ 24,844 $ 26,931 Accounts payable $ 35 $ 641 $ 676 $ 139 $ 5,093 $ 5,232 Accrued liabilities 2,752 519 3,271 2,939 5,037 7,976 Contract liabilities 197 25 222 197 302 499 Total current liabilities associated with discontinued operations 2,984 1,185 4,169 3,275 10,432 13,707 Other long-term liabilities 982 285 1,267 765 1,377 2,142 Total liabilities associated with discontinued operations $ 3,966 $ 1,470 $ 5,436 $ 4,040 $ 11,809 $ 15,849 |
Inventory (Tables)
Inventory (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | Inventory consisted of the following amounts (in thousands): June 30, 2021 December 31, 2020 Parts and supplies $ 65,626 $ 65,576 Work in progress 38,921 41,020 Finished goods 3,241 3,241 Inventory $ 107,788 $ 109,837 |
Property, Plant and Equipment_2
Property, Plant and Equipment, Net (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment, Net | Property, plant and equipment, net, consisted of the following (in thousands): June 30, 2021 December 31, 2020 Compression equipment, processing facilities and other fleet assets (1) $ 1,559,397 $ 1,562,528 Land and buildings 50,975 50,908 Transportation and shop equipment 53,712 54,763 Computer software 55,495 54,486 Other 43,029 40,305 1,762,608 1,762,990 Accumulated depreciation (1,099,471) (1,029,768) Property, plant and equipment, net $ 663,137 $ 733,222 (1) In the first quarter of 2021, we evaluated the salvage values of our property, plant and equipment. As a result of this evaluation, we changed the salvage values for our compression equipment to a maximum salvage value of 5% from 15%. During the three and six months ended June 30, 2021, we recorded an increase to depreciation expense of approximately $1.2 million and $2.1 million, respectively as a result of this change in salvage value. |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | Debt consisted of the following (in thousands): June 30, 2021 December 31, 2020 Revolving credit facility due October 2023 $ 227,000 $ 216,500 8.125% senior notes due May 2025 350,000 350,000 Other 1,285 — Unamortized deferred financing costs of 8.125% senior notes (3,693) (4,175) Total debt 574,592 562,325 Less: Amounts within one year (1) (1,285) — Long-term debt $ 573,307 $ 562,325 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table presents our assets and liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020, with pricing levels as of the date of valuation (in thousands): June 30, 2021 December 31, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Foreign currency derivatives liabilities $ — $ — $ — $ — $ — $ (247) |
Schedule of Assets and Liabilities Measured at Fair Value on Nonrecurring Basis | The following table presents our assets and liabilities measured at fair value on a nonrecurring basis during the six months ended June 30, 2021 and 2020, with pricing levels as of the date of valuation (in thousands): Six months ended June 30, 2021 Six months ended June 30, 2020 (Level 1) (Level 2) (Level 3) (Level 1) (Level 2) (Level 3) Impaired long-lived assets (1) $ — $ — $ — $ — $ — $ — Long-term note receivable (2) — — 12,119 — — 15,039 (1) Our estimate of the fair value of the impaired long-lived assets as of June 30, 2021, were primarily based on the expectation that these assets are unlikely to generate future cash flows either through continuation of this contract or through proceeds from the sale of the assets and thus they were written down to zero. (2) Our estimate of the fair value of a note receivable was discounted based on a settlement period of eight years and a discount rate of 12.5%. The undiscounted value of the note receivable, including interest, as of June 30, 2021 was $15.7 million. |
Restructuring and Other Charg_2
Restructuring and Other Charges (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Restructuring and Related Activities [Abstract] | |
Summary of Changes to Accrued Liability Balance Related to Restructuring and Other Charges | The following table summarizes the changes to our accrued liability balance related to restructuring and other charges for the six months ended June 30, 2021 and 2020 (in thousands): Cost Beginning balance at January 1, 2020 $ 2,281 Additions for costs expensed, net 3,312 Reductions for payments (1,050) Foreign exchange impact (404) Ending balance at June 30, 2020 $ 4,139 Beginning balance at January 1, 2021 $ 1,351 Additions for costs expensed, net 254 Reductions for payments (1,317) Foreign exchange impact 51 Ending balance at June 30, 2021 $ 339 |
Summary of the Components of Charges Included in Restructuring and Other Charges | The following table summarizes the components of charges included in restructuring and other charges in our statements of operations for the three and six months ended June 30, 2021 and 2020 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Employee termination benefits $ (441) $ 741 $ 183 $ 741 Legal fees 71 — 71 — Consulting fees — 2,364 — 2,571 Total restructuring and other charges $ (370) $ 3,105 $ 254 $ 3,312 The following table summarizes the components of charges included in restructuring and other charges incurred since the announcement of the cost reduction plan in the second quarter of 2019 (in thousands): Total Employee termination benefits $ 6,426 Legal fees 71 Consulting fees 3,205 Total restructuring and other charges $ 9,702 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Changes in Restricted Stock, Restricted Stock Units, and Performance Units | The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the six months ended June 30, 2021. Equity Awards Liability Awards Shares Weighted Average Shares Weighted Average Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 211 4.78 1,418 4.84 Vested (281) 13.16 (371) 14.02 Cancelled (10) 17.45 (47) 6.08 Non-vested awards, June 30, 2021 240 9.43 2,198 5.72 |
Schedule of Changes in Restricted Stock, Restricted Stock Units, and Performance Units | The table below presents the changes in restricted stock, restricted stock units and performance units for our common stock during the six months ended June 30, 2021. Equity Awards Liability Awards Shares Weighted Average Shares Weighted Average Non-vested awards, January 1, 2021 320 $ 16.02 1,198 $ 9.35 Granted 211 4.78 1,418 4.84 Vested (281) 13.16 (371) 14.02 Cancelled (10) 17.45 (47) 6.08 Non-vested awards, June 30, 2021 240 9.43 2,198 5.72 |
Net Income (Loss) Per Common _2
Net Income (Loss) Per Common Share (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Earnings Per Share [Abstract] | |
Reconciliation of Basic and Diluted Net Loss Per Common Share | The following table presents a reconciliation of basic and diluted net loss per common share for the three and six months ended June 30, 2021 and 2020 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2020 2021 2020 2021 2020 Numerator for basic and diluted net loss per common share: Loss from continuing operations $ (35,058) $ (19,285) $ (64,058) $ (35,358) Loss from discontinued operations, net of tax (156) (12,604) (1,029) (14,835) Less: Net income attributable to participating securities — — — — Net loss — used in basic and diluted net loss per common share $ (35,214) $ (31,889) $ (65,087) $ (50,193) Weighted average common shares outstanding including participating securities 33,350 33,175 33,289 33,161 Less: Weighted average participating securities outstanding (294) (372) (286) (441) Weighted average common shares outstanding — used in basic net loss per common share 33,056 32,803 33,003 32,720 Net dilutive potential common shares issuable: On exercise of options and vesting of restricted stock units * * * * Weighted average common shares outstanding — used in diluted net loss per common share 33,056 32,803 33,003 32,720 Net loss per common share: Basic and diluted $ (1.07) $ (0.97) $ (1.97) $ (1.53) * Excluded from diluted net income (loss) per common share as their inclusion would have been anti-dilutive. |
Schedule of Antidilutive Shares Excluded from Computation of Net Loss Per Common Share | The following table shows the potential shares of common stock issuable for the three and six months ended June 30, 2021 and 2020 that were excluded from computing diluted net loss per common share as their inclusion would have been anti-dilutive (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2021 2020 2021 2020 Net dilutive potential common shares issuable: On exercise of options where exercise price is greater than average market value — 30 — 43 Net dilutive potential common shares issuable — 30 — 43 |
Reportable Segments (Tables)
Reportable Segments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Revenues and Other Financial Information | The following table presents revenue and other financial information by reportable segment for the three and six months ended June 30, 2021 and 2020 (in thousands): Three months ended June 30, Contract Aftermarket Product sales (2) Reportable 2021 Revenue $ 87,498 $ 29,401 $ 29,300 $ 146,199 Adjusted gross margin (1) 59,734 5,979 2,191 67,904 2020 Revenue $ 77,945 $ 24,993 $ 28,119 $ 131,057 Adjusted gross margin (1) 54,199 5,973 (4,268) 55,904 Six months ended June 30, Contract Aftermarket Product sales (2) Reportable 2021 Revenue $ 168,512 $ 54,521 $ 59,330 $ 282,363 Adjusted gross margin (1) 117,404 11,087 6,648 135,139 2020 Revenue $ 172,733 $ 52,902 $ 66,216 $ 291,851 Adjusted gross margin (1) 117,527 12,701 (5,102) 125,126 (1) Adjusted gross margin is defined as revenue less cost of sales (excluding depreciation and amortization expense). |
Reconciliation of Total Gross Margin to Total Adjusted Gross Margin | The following table reconciles total gross margin to total adjusted gross margin (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenues $ 146,199 $ 131,057 $ 282,363 $ 291,851 Cost of sales (excluding depreciation and amortization expenses) 78,295 75,153 147,224 166,725 Depreciation and amortization (1) 44,017 30,861 84,852 61,307 Total gross margin 23,887 25,043 50,287 63,819 Depreciation and amortization (1) 44,017 30,861 84,852 61,307 Total adjusted gross margin $ 67,904 $ 55,904 $ 135,139 $ 125,126 (1) Represents the portion only attributable to cost of sales. |
Description of Business and B_3
Description of Business and Basis of Presentation - Narrative (Details) | 6 Months Ended |
Jun. 30, 2021business_line | |
Accounting Policies [Abstract] | |
Number of business lines | 3 |
Revenue - Disaggregation by Pro
Revenue - Disaggregation by Products and Services (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 146,199 | $ 131,057 | $ 282,363 | $ 291,851 |
Contract operations | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 87,498 | 77,945 | 168,512 | 172,733 |
Contract operations | Revenue recognized over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 87,498 | 77,945 | 168,512 | 172,733 |
Aftermarket services | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 29,401 | 24,993 | 54,521 | 52,902 |
Aftermarket services | Operation and maintenance services | Revenue recognized over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 12,474 | 12,279 | 24,516 | 25,218 |
Aftermarket services | Part sales | Revenue recognized at a point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 13,272 | 9,685 | 22,322 | 20,509 |
Aftermarket services | Other services | Revenue recognized over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 3,655 | 3,029 | 7,683 | 7,175 |
Product sales | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 29,300 | 28,119 | 59,330 | 66,216 |
Product sales | Compression equipment | Revenue recognized over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 2,646 | 14,198 | 7,972 | 33,354 |
Product sales | Processing and treating equipment | Revenue recognized over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 22,331 | 8,807 | 43,890 | 20,616 |
Product sales | Other product sales | Transferred over time and transferred at point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 4,323 | $ 5,114 | $ 7,468 | $ 12,246 |
Revenue - Disaggregation by Geo
Revenue - Disaggregation by Geographical Regions (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 146,199 | $ 131,057 | $ 282,363 | $ 291,851 |
North America | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 3,100 | 9,354 | 9,425 | 18,330 |
Latin America | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 68,592 | 58,352 | 129,210 | 135,149 |
Middle East and Africa | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 61,979 | 52,373 | 119,158 | 108,086 |
Asia Pacific | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 12,528 | $ 10,978 | $ 24,570 | $ 30,286 |
Revenue - Performance Obligatio
Revenue - Performance Obligations (Details) $ in Thousands | Jun. 30, 2021USD ($) |
Contract operations | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 1,186,943 |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 148,930 |
Expected timing of satisfaction, period | 6 months |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 216,340 |
Expected timing of satisfaction, period | 1 year |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 207,066 |
Expected timing of satisfaction, period | 1 year |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 191,391 |
Expected timing of satisfaction, period | 1 year |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 170,595 |
Expected timing of satisfaction, period | 1 year |
Contract operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 252,621 |
Expected timing of satisfaction, period | |
Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 410,790 |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 132,010 |
Expected timing of satisfaction, period | 6 months |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 205,073 |
Expected timing of satisfaction, period | 1 year |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 43,670 |
Expected timing of satisfaction, period | 1 year |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 12,480 |
Expected timing of satisfaction, period | 1 year |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 17,557 |
Expected timing of satisfaction, period | 1 year |
Product sales | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 0 |
Expected timing of satisfaction, period |
Revenue - Expected Timing of Re
Revenue - Expected Timing of Revenue Recognition (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2021USD ($) | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Operating lease income | $ 18,000 |
Revenue recognized from contract operations services including revenue deferred in previous periods | 35,500 |
Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | 331,800 |
Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | 410,790 |
Performance obligation satisfied in previous periods | 50,800 |
Performance obligation satisfied in previous periods, included in billings in excess of costs | 27,700 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01 | Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 19,000 |
Expected timing of satisfaction, period | 6 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 132,010 |
Expected timing of satisfaction, period | 6 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 44,000 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 205,073 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 87,000 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 43,670 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 76,000 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 12,480 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Operating lease contracts | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 61,000 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 17,557 |
Expected timing of satisfaction, period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 0 |
Expected timing of satisfaction, period | |
Financing | Product sales | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Expected timing of revenue recognition from unsatisfied performance obligations | $ 43,000 |
Revenue - Contract Assets and C
Revenue - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Revenue from Contract with Customer [Abstract] | ||
Accounts receivables, net | $ 202,899 | $ 198,028 |
Contract assets and contract liabilities: | ||
Current contract assets | 32,528 | 32,642 |
Long-term contract assets | 17,537 | 33,563 |
Current contract liabilities | 94,669 | 100,123 |
Long-term contract liabilities | $ 69,804 | $ 80,499 |
Revenue - Allowance for Doubtfu
Revenue - Allowance for Doubtful Accounts (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2021USD ($) | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | $ 10,803 |
Write-offs during the period | (496) |
Ending balance | $ 10,307 |
Discontinued Operations - Summa
Discontinued Operations - Summary of Operating Results (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Impairments | $ 7,959 | $ 0 | $ 7,959 | $ 0 |
Loss from discontinued operations, net of tax | (156) | (12,604) | (1,029) | (14,835) |
Discontinued Operations | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Revenue | 0 | 40,568 | 53 | 90,255 |
Cost of sales (excluding depreciation and amortization expense) | (37) | 38,525 | 227 | 84,129 |
Selling, general and administrative | 104 | 2,965 | 657 | 7,570 |
Depreciation and amortization | 0 | 665 | 0 | 1,324 |
Impairments | 0 | 6,512 | 0 | 6,512 |
Restructuring and other charges | 0 | 4,572 | 0 | 5,553 |
Other expense, net | 59 | 5 | 93 | 49 |
Provision for (benefit from) income taxes | 30 | (72) | 105 | (47) |
Loss from discontinued operations, net of tax | (156) | (12,604) | (1,029) | (14,835) |
Belleli EPC | Exit of Business | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Revenue | 0 | 0 | 0 | 124 |
Cost of sales (excluding depreciation and amortization expense) | 0 | 88 | 55 | 184 |
Selling, general and administrative | 86 | 101 | 244 | 214 |
Depreciation and amortization | 0 | 0 | 0 | 0 |
Impairments | 0 | 0 | 0 | 0 |
Restructuring and other charges | 0 | 0 | 0 | 0 |
Other expense, net | 0 | 5 | 34 | 49 |
Provision for (benefit from) income taxes | 30 | (72) | 105 | (47) |
Loss from discontinued operations, net of tax | (116) | (122) | (438) | (276) |
US Compression | Disposed of by Sale | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Revenue | 0 | 40,568 | 53 | 90,131 |
Cost of sales (excluding depreciation and amortization expense) | (37) | 38,437 | 172 | 83,945 |
Selling, general and administrative | 18 | 2,864 | 413 | 7,356 |
Depreciation and amortization | 0 | 665 | 0 | 1,324 |
Impairments | 0 | 6,512 | 0 | 6,512 |
Restructuring and other charges | 0 | 4,572 | 0 | 5,553 |
Other expense, net | 59 | 0 | 59 | 0 |
Provision for (benefit from) income taxes | 0 | 0 | 0 | 0 |
Loss from discontinued operations, net of tax | $ (40) | $ (12,482) | $ (591) | $ (14,559) |
Discontinued Operations - Sum_2
Discontinued Operations - Summary of Balance Sheet Data (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contract assets | $ 32,528 | $ 32,642 |
Total current assets associated with discontinued operations | 21,795 | 25,325 |
Total current liabilities associated with discontinued operations | 4,169 | 13,707 |
Discontinued Operations | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Accounts receivable | 369 | 3,439 |
Inventory | 21,006 | 21,107 |
Contract assets | 247 | 458 |
Other current assets | 173 | 321 |
Total current assets associated with discontinued operations | 21,795 | 25,325 |
Intangible and other assets, net | 1,687 | 1,606 |
Total assets associated with discontinued operations | 23,482 | 26,931 |
Accounts payable | 676 | 5,232 |
Accrued liabilities | 3,271 | 7,976 |
Contract liabilities | 222 | 499 |
Total current liabilities associated with discontinued operations | 4,169 | 13,707 |
Other long-term liabilities | 1,267 | 2,142 |
Total liabilities associated with discontinued operations | 5,436 | 15,849 |
Belleli EPC | Exit of Business | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Accounts receivable | 268 | 268 |
Inventory | 0 | 0 |
Contract assets | 0 | 0 |
Other current assets | 173 | 213 |
Total current assets associated with discontinued operations | 441 | 481 |
Intangible and other assets, net | 1,687 | 1,606 |
Total assets associated with discontinued operations | 2,128 | 2,087 |
Accounts payable | 35 | 139 |
Accrued liabilities | 2,752 | 2,939 |
Contract liabilities | 197 | 197 |
Total current liabilities associated with discontinued operations | 2,984 | 3,275 |
Other long-term liabilities | 982 | 765 |
Total liabilities associated with discontinued operations | 3,966 | 4,040 |
US Compression | Disposed of by Sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Accounts receivable | 101 | 3,171 |
Inventory | 21,006 | 21,107 |
Contract assets | 247 | 458 |
Other current assets | 0 | 108 |
Total current assets associated with discontinued operations | 21,354 | 24,844 |
Intangible and other assets, net | 0 | 0 |
Total assets associated with discontinued operations | 21,354 | 24,844 |
Accounts payable | 641 | 5,093 |
Accrued liabilities | 519 | 5,037 |
Contract liabilities | 25 | 302 |
Total current liabilities associated with discontinued operations | 1,185 | 10,432 |
Other long-term liabilities | 285 | 1,377 |
Total liabilities associated with discontinued operations | $ 1,470 | $ 11,809 |
Inventory (Details)
Inventory (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Composition of Inventory net of reserves | ||
Parts and supplies | $ 65,626 | $ 65,576 |
Work in progress | 38,921 | 41,020 |
Finished goods | 3,241 | 3,241 |
Inventory | $ 107,788 | $ 109,837 |
Property, Plant and Equipment_3
Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | |
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | $ 1,762,608 | $ 1,762,608 | $ 1,762,990 | |
Accumulated depreciation | (1,099,471) | (1,099,471) | (1,029,768) | |
Property, plant and equipment, net | 663,137 | 663,137 | 733,222 | |
Compression equipment, processing facilities and other fleet assets | ||||
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | 1,559,397 | 1,559,397 | $ 1,562,528 | |
Compression equipment, processing facilities and other fleet assets | Salvage Value | ||||
Property, Plant and Equipment | ||||
Salvage value (in percent) | 5.00% | 15.00% | ||
Depreciation expense | 1,200 | 2,100 | ||
Land and buildings | ||||
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | 50,975 | 50,975 | $ 50,908 | |
Transportation and shop equipment | ||||
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | 53,712 | 53,712 | 54,763 | |
Computer software | ||||
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | 55,495 | 55,495 | 54,486 | |
Other | ||||
Property, Plant and Equipment | ||||
Property, plant and equipment, gross | $ 43,029 | $ 43,029 | $ 40,305 |
Debt - Schedule of Debt (Detail
Debt - Schedule of Debt (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Debt Instrument [Line Items] | ||
Other | $ 1,285 | $ 0 |
Total debt | 574,592 | 562,325 |
Less: Amounts due within one year | (1,285) | 0 |
Long-term debt (Note 6) | 573,307 | 562,325 |
8.125% senior notes due May 2025 | Senior Notes | ||
Debt Instrument [Line Items] | ||
Long-term Debt | 350,000 | 350,000 |
Unamortized deferred financing costs of 8.125% senior notes | $ (3,693) | (4,175) |
Stated interest rate | 8.125% | |
Revolving credit facility due October 2023 | ||
Debt Instrument [Line Items] | ||
Long-term Debt | $ 227,000 | $ 216,500 |
Debt - Revolving Credit Facilit
Debt - Revolving Credit Facility (Narrative) (Details) | Jun. 30, 2021USD ($) |
Debt Instrument [Line Items] | |
Outstanding letters of credit | $ 59,400,000 |
Revolving credit facility | Amended Credit Agreement | |
Debt Instrument [Line Items] | |
Borrowing capacity under restated credit agreement | 650,000,000 |
Revolving credit facility | Credit Agreement | |
Debt Instrument [Line Items] | |
Outstanding borrowings | 227,000,000 |
Outstanding letters of credit | 28,000,000 |
Undrawn capacity under revolving credit facility | $ 395,000,000 |
Total debt to EBITDA ratio | 4.50 |
Undrawn capacity available | $ 147,800,000 |
Debt - 8.125% Senior Notes Due
Debt - 8.125% Senior Notes Due May 2025 (Narrative) (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
Jul. 31, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | Apr. 30, 2017 | |
Debt Instrument [Line Items] | |||||||
Repayments of debt | $ 110,900,000 | $ 183,316,000 | |||||
Gain on extinguishment of debt | $ 0 | $ 2,644,000 | $ 0 | $ 2,644,000 | |||
Interest coverage ratio | 5.7 | 5.7 | |||||
Total leverage ratio | 3.6 | 3.6 | |||||
Senior secured leverage ratio | 1.4 | 1.4 | |||||
Revolving credit facility due October 2023 | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | $ 227,000,000 | $ 227,000,000 | $ 216,500,000 | ||||
Amended Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Maximum interest coverage ratio | 2.25 | 2.25 | |||||
Maximum total leverage ratio | 4.50 | 4.50 | |||||
Maximum senior secured leverage ratio | 2.75 | 2.75 | |||||
Subsidiaries | Exterran Corporation | EESLP And EES Finance Corp. | |||||||
Debt Instrument [Line Items] | |||||||
Ownership percentage by parent | 100.00% | ||||||
8.125% senior notes due May 2025 | Senior unsecured notes | |||||||
Debt Instrument [Line Items] | |||||||
Stated interest rate | 8.125% | 8.125% | |||||
Long-term Debt | $ 350,000,000 | $ 350,000,000 | $ 350,000,000 | ||||
Amount of debt extinguished | $ 5,000,000 | 19,000,000 | |||||
Repayments of debt | 4,300,000 | 16,300,000 | |||||
Payments for accrued interest | $ 100,000 | 200,000 | |||||
Gain on extinguishment of debt | 2,600,000 | ||||||
Write off of deferred financing cost | $ 200,000 | ||||||
8.125% senior notes due May 2025 | Subsidiaries | Senior unsecured notes | EESLP And EES Finance Corp. | |||||||
Debt Instrument [Line Items] | |||||||
Stated interest rate | 8.125% | ||||||
Aggregate principal amount of senior unsecured notes | $ 375,000,000 |
Fair Value Measurements - Recur
Fair Value Measurements - Recurring Measurements (Details) - Fair Value, Recurring - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
(Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Foreign currency derivatives liabilities | $ 0 | $ 0 |
(Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Foreign currency derivatives liabilities | 0 | 0 |
(Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Foreign currency derivatives liabilities | $ 0 | $ (247) |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | |
Foreign Exchange Contract | |||
Summary of assets and liabilities measured at fair value | |||
Loss recognized on forward currency exchange contracts | $ 1.1 | $ 2 | |
Senior Notes | 8.125% senior notes due May 2025 | Reported Value Measurement | |||
Summary of assets and liabilities measured at fair value | |||
Fair value of notes | 350 | 350 | $ 350 |
Senior Notes | 8.125% senior notes due May 2025 | Estimate of Fair Value Measurement | |||
Summary of assets and liabilities measured at fair value | |||
Fair value of notes | $ 312 | $ 312 | $ 297 |
Fair Value Measurements - Nonre
Fair Value Measurements - Nonrecurring Measurements (Details) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021USD ($) | Jun. 30, 2020USD ($) | |
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Undiscounted value of note receivable Including Interest | $ 15,700 | |
Nonrecurring | Maturiy | ||
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Settlement period | 8 years | |
Nonrecurring | Discount rate | ||
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Discount rate | 0.125 | |
Nonrecurring | (Level 1) | ||
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Impaired long-lived assets | $ 0 | $ 0 |
Long-term note receivable | 0 | 0 |
Nonrecurring | (Level 2) | ||
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Impaired long-lived assets | 0 | 0 |
Long-term note receivable | 0 | 0 |
Nonrecurring | (Level 3) | ||
Summary of assets and liabilities measured at fair value on nonrecurring basis | ||
Impaired long-lived assets | 0 | 0 |
Long-term note receivable | $ 12,119 | $ 15,039 |
Impairments (Details)
Impairments (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Asset Impairment Charges [Abstract] | ||||
Impairments | $ 7,959 | $ 0 | $ 7,959 | $ 0 |
Restructuring and Other Charg_3
Restructuring and Other Charges - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges | $ (370) | $ 3,105 | $ 254 | $ 3,312 |
Cost Reduction Plan | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges | $ (400) | $ 3,100 | $ 300 | $ 3,300 |
Restructuring and Other Charg_4
Restructuring and Other Charges - Summary of Charges to Accrued Liability Balance (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Restructuring Reserve [Roll Forward] | ||||
Restructuring and other charges | $ (370) | $ 3,105 | $ 254 | $ 3,312 |
Restructuring and other charges incurred to date | 9,702 | 9,702 | ||
Employee termination benefits | ||||
Restructuring Reserve [Roll Forward] | ||||
Restructuring and other charges | (441) | 741 | 183 | 741 |
Restructuring and other charges incurred to date | 6,426 | 6,426 | ||
Consulting fees | ||||
Restructuring Reserve [Roll Forward] | ||||
Restructuring and other charges | 0 | 2,364 | 0 | 2,571 |
Restructuring and other charges incurred to date | 3,205 | 3,205 | ||
Legal Fees | ||||
Restructuring Reserve [Roll Forward] | ||||
Restructuring and other charges | 71 | 0 | 71 | 0 |
Restructuring and other charges incurred to date | 71 | 71 | ||
Cost Reduction Plan | ||||
Restructuring Reserve [Roll Forward] | ||||
Beginning balance | 1,351 | 2,281 | ||
Additions for costs expensed, net | 254 | 3,312 | ||
Reductions for payments | (1,317) | (1,050) | ||
Foreign exchange impact | 51 | (404) | ||
Ending balance | 339 | 4,139 | 339 | 4,139 |
Restructuring and other charges | $ (400) | $ 3,100 | $ 300 | $ 3,300 |
Provision for Income Taxes (Det
Provision for Income Taxes (Details) | 3 Months Ended | 6 Months Ended |
Jun. 30, 2021 | Jun. 30, 2021 | |
Income Tax Disclosure [Abstract] | ||
Federal income tax rate | 21.00% | 21.00% |
Effective tax rate | (33.70%) | (34.10%) |
Unrecognized tax benefits due to FIN 48 | (5.70%) | |
Foreign currency devaluation | (10.90%) | (11.50%) |
Foreign withholding tax rate differential | (19.60%) | (19.90%) |
Deemed inclusion in the US | (11.60%) | (12.00%) |
Deferred tax assets valuation | (4.10%) | (6.60%) |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Feb. 20, 2019 | |
Equity [Abstract] | |||
Share repurchase program, authorized purchase amount | $ 100,000,000 | ||
Shares repurchased (in shares) | 0 | 0 | |
Remaining authorized share repurchase amount | $ 57,700,000 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Stock options granted (in shares) | 0 | 0 |
Restricted stock, restricted stock units and performance units for common stock | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Estimated unrecognized compensation cost | $ 8.4 | |
Weighted-average vesting period | 1 year 4 months 24 days | |
Minimum | Restricted stock, restricted stock units and performance units for common stock | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period | 2 years | |
Maximum | Restricted stock, restricted stock units and performance units for common stock | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period | 3 years |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Restricted Stock, Restricted Stock Units and Performance Units for Common Stock (Details) shares in Thousands | 6 Months Ended |
Jun. 30, 2021$ / sharesshares | |
Equity Awards | |
Shares | |
Non-vested awards at the beginning of the period | shares | 320 |
Granted | shares | 211 |
Vested | shares | (281) |
Cancelled | shares | (10) |
Non-vested awards at the end of the period | shares | 240 |
Weighted Average Grant-Date Fair Value Per Share | |
Non-vested awards at the beginning of the period (in dollars per share) | $ / shares | $ 16.02 |
Granted (in dollars per share) | $ / shares | 4.78 |
Vested (in dollars per share) | $ / shares | 13.16 |
Cancelled (in dollars per share) | $ / shares | 17.45 |
Non-vested awards at the end of the period (in dollars per share) | $ / shares | $ 9.43 |
Liability Awards | |
Shares | |
Non-vested awards at the beginning of the period | shares | 1,198 |
Granted | shares | 1,418 |
Vested | shares | (371) |
Cancelled | shares | (47) |
Non-vested awards at the end of the period | shares | 2,198 |
Weighted Average Grant-Date Fair Value Per Share | |
Non-vested awards at the beginning of the period (in dollars per share) | $ / shares | $ 9.35 |
Granted (in dollars per share) | $ / shares | 4.84 |
Vested (in dollars per share) | $ / shares | 14.02 |
Cancelled (in dollars per share) | $ / shares | 6.08 |
Non-vested awards at the end of the period (in dollars per share) | $ / shares | $ 5.72 |
Net Income (Loss) Per Common _3
Net Income (Loss) Per Common Share - Reconciliation of Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Numerator for basic and diluted net loss per common share: | ||||
Loss from continuing operations | $ (35,058) | $ (19,285) | $ (64,058) | $ (35,358) |
Loss from discontinued operations, net of tax | (156) | (12,604) | (1,029) | (14,835) |
Less: Net income attributable to participating securities | 0 | 0 | 0 | 0 |
Net loss — used in basic and diluted net loss per common share | $ (35,214) | $ (31,889) | $ (65,087) | $ (50,193) |
Weighted average common shares outstanding including participating securities | ||||
Weighted average common shares outstanding including participating securities (in shares) | 33,350 | 33,175 | 33,289 | 33,161 |
Less: Weighted average participating securities outstanding (in shares) | (294) | (372) | (286) | (441) |
Weighted average common shares outstanding — used in basic net loss per common share (in shares) | 33,056 | 32,803 | 33,003 | 32,720 |
Net dilutive potential common shares issuable: | ||||
Weighted average common shares outstanding — used in diluted net loss per common share (in shares) | 33,056 | 32,803 | 33,003 | 32,720 |
Net loss per common share: | ||||
Basic (in dollars per share) | $ (1.07) | $ (0.97) | $ (1.97) | $ (1.53) |
Diluted (in dollars per share) | $ (1.07) | $ (0.97) | $ (1.97) | $ (1.53) |
Net Income (Loss) Per Common _4
Net Income (Loss) Per Common Share - Schedule of Antidilutive Shares (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Net dilutive potential common shares issuable (in shares) | 0 | 30 | 0 | 43 |
On exercise of options where exercise price is greater than average market value | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Net dilutive potential common shares issuable (in shares) | 0 | 30 | 0 | 43 |
Commitments and Contingencies -
Commitments and Contingencies - Contingencies (Details) - USD ($) $ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Commitments and Contingencies Disclosure [Abstract] | ||
Outstanding letters of credit | $ 59.4 | |
Amount accrued for the outcomes of non-income-based tax audits | $ 1.5 | $ 3.5 |
Commitments and Contingencies_2
Commitments and Contingencies - Litigation (Details) - USD ($) $ in Millions | Jul. 05, 2021 | May 11, 2021 | Dec. 19, 2020 | Apr. 27, 2021 |
Loss Contingencies [Line Items] | ||||
Amount of Legal Claim | $ 1 | $ 38 | ||
Subsequent Event | ||||
Loss Contingencies [Line Items] | ||||
Amount of Legal Claim | $ 13 | |||
Pending litigation | ||||
Loss Contingencies [Line Items] | ||||
Estimate of possible loss | $ 27 | |||
Threatened litigation | ||||
Loss Contingencies [Line Items] | ||||
Estimate of possible loss | $ 12 |
Reportable Segments - Narrative
Reportable Segments - Narrative (Details) | 6 Months Ended |
Jun. 30, 2021segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 3 |
Reportable Segments - Schedule
Reportable Segments - Schedule of Revenues and Other Financial Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Segment Reporting Information [Line Items] | ||||
Revenue | $ 146,199 | $ 131,057 | $ 282,363 | $ 291,851 |
Total adjusted gross margin | 67,904 | 55,904 | 135,139 | 125,126 |
Operating Segments | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 146,199 | 131,057 | 282,363 | 291,851 |
Total adjusted gross margin | 67,904 | 55,904 | 135,139 | 125,126 |
Contract operations | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 87,498 | 77,945 | 168,512 | 172,733 |
Contract operations | Operating Segments | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 87,498 | 77,945 | 168,512 | 172,733 |
Total adjusted gross margin | 59,734 | 54,199 | 117,404 | 117,527 |
Aftermarket Services | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 29,401 | 24,993 | 54,521 | 52,902 |
Aftermarket Services | Operating Segments | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 29,401 | 24,993 | 54,521 | 52,902 |
Total adjusted gross margin | 5,979 | 5,973 | 11,087 | 12,701 |
Product sales | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 29,300 | 28,119 | 59,330 | 66,216 |
Product sales | Operating Segments | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 29,300 | 28,119 | 59,330 | 66,216 |
Total adjusted gross margin | $ 2,191 | $ (4,268) | $ 6,648 | $ (5,102) |
Reportable Segments - Reconcili
Reportable Segments - Reconciliation of Total Gross Margin to Total Adjusted Gross Margin (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Segment Reporting [Abstract] | ||||
Revenue | $ 146,199 | $ 131,057 | $ 282,363 | $ 291,851 |
Cost of sales (excluding depreciation and amortization expense): | 78,295 | 75,153 | 147,224 | 166,725 |
Depreciation and amortization | 44,017 | 30,861 | 84,852 | 61,307 |
Total gross margin | 23,887 | 25,043 | 50,287 | 63,819 |
Total adjusted gross margin | $ 67,904 | $ 55,904 | $ 135,139 | $ 125,126 |